or Try an Advanced Search...

    Technical Analysis for MSB - Mesoblast limited  

    Grade Last Price % Change Price Change
    B 1.505 1.35% 0.020
    MSB closed up 1.35 percent on Friday, November 22, 2024, on approximately normal volume.
    Earnings due: Nov 27
    *** please verify all earnings dates ***
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical MSB trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    20 DMA Support Bullish 0.00%
    Calm After Storm Range Contraction 0.00%
    Doji - Bullish? Reversal 0.00%
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion 1.35%
    Calm After Storm Range Contraction -4.44%
    Wide Bands Range Expansion -4.44%
    Calm After Storm Range Contraction -6.23%
    NR7 Range Contraction -6.23%
    Older End-of-Day Signals for MSB ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Support about 16 hours ago
    Down 3% about 17 hours ago
    Fell Below 20 DMA about 17 hours ago
    Down 2% about 17 hours ago
    Fell Below Previous Day's Low about 17 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    MSB Chart by TradingView
    Basic chart:

    Profile

    Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs, including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Disease Diseases Life Sciences Biology Disorders Stem Cell Stem Cells Cell Biology Induced Stem Cells

    Is MSB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Mesoblast Issues 2 Million Warrants for Strategic Flexibility
    Nov 8 ASX Growth Companies With High Insider Ownership Seeing Up To 61% Earnings Growth
    Nov 6 Three High Growth Tech Stocks in Australia
    Oct 30 Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024
    Oct 30 When Will Mesoblast Limited (ASX:MSB) Become Profitable?
    Oct 19 Mesoblast Advances Cellular Medicines Amid FDA Hopes
    Oct 9 3 ASX Growth Companies With Insider Ownership Up To 37%
    Oct 9 3 ASX Growth Stocks With Insider Ownership Up To 36%
    Oct 8 Exploring High Growth Tech Stocks In Australia
    Oct 8 3 ASX Growth Stocks Insiders Own With Up To 45% Revenue Growth
    See more MSB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.83
    52 Week Low 0.255
    Average Volume 4,431,337
    200-Day Moving Average 0.985
    50-Day Moving Average 1.329
    20-Day Moving Average 1.444
    10-Day Moving Average 1.560
    Average True Range 0.098
    RSI (14) 54.34
    ADX 31.65
    +DI 31.236
    -DI 25.952
    Chandelier Exit (Long, 3 ATRs) 1.536
    Chandelier Exit (Short, 3 ATRs) 1.549
    Upper Bollinger Bands 1.709
    Lower Bollinger Band 1.178
    Percent B (%b) 0.62
    BandWidth 36.764
    MACD Line 0.067
    MACD Signal Line 0.068
    MACD Histogram -0.0007
    Fundamentals Value
    Market Cap 884.32 Million
    Num Shares 588 Million
    EPS -0.18
    Price-to-Earnings (P/E) Ratio -8.27
    Price-to-Sales 109.07
    Price-to-Book 3.26
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.640
    Resistance 3 (R3) 1.630 1.575 1.618
    Resistance 2 (R2) 1.575 1.541 1.580 1.610
    Resistance 1 (R1) 1.540 1.519 1.550 1.550 1.602
    Pivot Point 1.485 1.485 1.490 1.490 1.485
    Support 1 (S1) 1.450 1.451 1.460 1.460 1.408
    Support 2 (S2) 1.395 1.429 1.400 1.400
    Support 3 (S3) 1.360 1.395 1.393
    Support 4 (S4) 1.370